We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-13.49%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$42.1B
AUM Growth
-$7.13B
(-14%)
Cap. Flow
+$617M
Cap. Flow
% of AUM
1.47%
Top 10 Holdings %
Top 10 Hldgs %
24.6%
Holding
2,253
New
45
Increased
584
Reduced
402
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$209M |
| 2 |
AT&T
T
|
+$156M |
| 3 |
ExxonMobil
XOM
|
+$122M |
| 4 |
Johnson & Johnson
JNJ
|
+$84.2M |
| 5 |
Walmart Inc
WMT
|
+$77.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$209M |
| 2 |
Chevron
CVX
|
+$115M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$95.1M |
| 4 |
Meta Platforms (Facebook)
META
|
+$80.8M |
| 5 |
Eli Lilly
LLY
|
+$66.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.42% |
| 2 | Healthcare | 18.92% |
| 3 | Financials | 13.22% |
| 4 | Consumer Discretionary | 8.69% |
| 5 | Industrials | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Adaptive Biotechnologies
ADPT
$3.57B
| $119K | ﹤0.01% |
14,700
-14,562
| -50% | -$128K |
|
|
JOYY
1927
JOYY Inc
JOYY
$3.77B
| $119K | ﹤0.01% |
4,000
| – | – |
|
1928
PAR Technology
PAR
$683M
| $118K | ﹤0.01% |
3,160
| – | – |
|
1929
Ocular Therapeutix
OCUL
$1.88B
| $117K | ﹤0.01% |
29,050
| – | – |
|
1930
TaskUs
TASK
$545M
| $117K | ﹤0.01% |
6,960
| – | – |
|
1931
Legend Biotech
LEGN
$3.69B
| $116K | ﹤0.01% |
2,100
| – | – |
|
1932
Nelnet
NNI
$4.81B
| $115K | ﹤0.01% |
1,350
| – | – |
|
1933
Veru
VERU
$37.1M
| $115K | ﹤0.01% |
1,022
+160
| +19% | +$18.6K |
|
|
JMIA
1934
Jumia Technologies
JMIA
$754M
| $113K | ﹤0.01% |
18,646
| – | – |
|
|
ONT
1935
Onterris Inc
ONT
$720M
| $113K | ﹤0.01% |
3,340
| – | – |
|
1936
ZIM Integrated Shipping Services
ZIM
$2.97B
| $113K | ﹤0.01% |
+2,400
| New | +$141K |
|
1937
Bausch Health
BHC
$1.7B
| $112K | ﹤0.01% |
13,100
| – | – |
|
|
EB
1938
DELISTED
Eventbrite
EB
| $112K | ﹤0.01% |
10,890
| – | – |
|
|
ONL
1939
Orion Office REIT
ONL
$150M
| $112K | ﹤0.01% |
10,227
-343
| -3% | -$4.43K |
|
|
OTLY
1940
Oatly Group
OTLY
$448M
| $112K | ﹤0.01% |
1,623
+280
| +21% | +$21.9K |
|
1941
Alamo Group
ALG
$2B
| $111K | ﹤0.01% |
950
| – | – |
|
1942
Clear Secure
YOU
$5.41B
| $111K | ﹤0.01% |
5,540
+1,480
| +36% | +$39.9K |
|
1943
Lightspeed Commerce
LSPD
$1.35B
| $109K | ﹤0.01% |
4,800
+300
| +7% | +$7.06K |
|
1944
Qfin Holdings
QFIN
$1.64B
| $109K | ﹤0.01% |
6,300
| – | – |
|
1945
NBT Bancorp
NBTB
$2.73B
| $108K | ﹤0.01% |
2,880
| – | – |
|
1946
SkinHealth Systems
SKIN
$100M
| $107K | ﹤0.01% |
+8,310
| New | +$111K |
|
|
ATYR
1947
aTyr Pharma
ATYR
$47.1M
| $107K | ﹤0.01% |
37,884
| – | – |
|
1948
Seres Therapeutics
MCRB
$48.1M
| $106K | ﹤0.01% |
1,539
| – | – |
|
1949
Newmark Group
NMRK
$2.81B
| $106K | ﹤0.01% |
10,960
| – | – |
|
1950
Rocket Pharmaceuticals
RCKT
$359M
| $106K | ﹤0.01% |
7,730
| – | – |
|
Similar funds
SCP
Ensign Peak Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Ensign Peak Advisors held 2,253 positions worth $42.1B, down 14% from $49.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q2 2022 filing shows 45 new, 584 increased, 402 reduced and 95 closed positions. Its largest new stake was State Street Utilities Select Sector SPDR ETF: 455,528 shares worth $16M. The largest sale was iShares Russell 2000 ETF, an estimated $209M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q2 2022 buy was State Street Utilities Select Sector SPDR ETF: 455,528 shares worth $16M.
- Ensign Peak Advisors added most to Merck in Q2 2022, an estimated $209M increase.
- Ensign Peak Advisors's biggest Q2 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $209M.
- Ensign Peak Advisors fully exited VMware, Inc in Q2 2022, selling an estimated $20.8M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $42.1B portfolio in Q2 2022.
- Ensign Peak Advisors opened 45 new positions and closed 95 in Q2 2022.
- Ensign Peak Advisors's portfolio value fell 14% quarter-over-quarter to $42.1B.
Based on Ensign Peak Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.